A Bombesin-Shepherdin Radioconjugate Designed for Combined Extra- and Intracellular Targeting
Radiolabeled peptides which target tumor-specific membrane structures of cancer cells represent a promising class of targeted radiopharmaceuticals for the diagnosis and therapy of cancer. A potential drawback of a number of reported radiopeptides is the rapid washout of a substantial fraction of the...
Saved in:
Main Authors: | Christiane A. Fischer (Author), Sandra Vomstein (Author), Thomas L. Mindt (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2014-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vitro Biological Evaluation of Aprepitant Based <sup>177</sup>Lu-Radioconjugates
by: Paweł K. Halik, et al.
Published: (2022) -
Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer
by: Truc T. Huynh, et al.
Published: (2022) -
Diagnosis of Prostate Cancer with a Neurotensin-Bombesin Radioligand Combination-First Preclinical Results
by: Maria Bibika, et al.
Published: (2024) -
Designed Multifunctional Peptides for Intracellular Targets
by: Davor Juretić
Published: (2022) -
Bombesins: A New Frontier in Hybrid Compound Development
by: Pawel Serafin, et al.
Published: (2023)